Back to VRDN
Candriam S.C.A. VRDN Position History
Viridian Therapeutics, Inc. • Healthcare
Quarters held
6
Latest value
$31.6M
Q3 2026
Peak value
$31.6M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $18.6M |
| Q4 2025 | $24.4M |
| Q4 2025 | $24.4M |
| Q1 2026 | $13.9M |
| Q2 2026 | $31.3M |
| Q3 2026 | $31.6M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $31.6M | 1.53M | — | — |
| Q2 2026 | $31.3M | 1.71M | — | — |
| Q1 2026 | $13.9M | 711.7K | — | — |
| Q4 2025 | $24.4M | 785.1K | — | — |
| Q4 2025 | $24.4M | 785.1K | — | — |
| Q3 2025 | $18.6M | 860.2K | — | — |
Other funds holding VRDN
$112.5M
$112.5M
$91.4M
$46.7M
$42.8M